Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Acute pancreatitis: possible association of dimethyl fumarate for the treatment of relapsing-remitting multiple sclerosis.
Interferons beta have vasoconstrictive and procoagulant effects: A woman who developed livedo reticularis and Raynaud phenomenon in association with interferon beta treatment for multiple sclerosis.
Alemtuzumab and multiple sclerosis: therapeutic application.
Control of oxidative stress and inflammation in sickle cell disease with the Nrf2 activator dimethyl fumarate.
A genetic screen identifies genes essential for development of myelinated axons in zebrafish.
Impact of MS during the critical window of brain development.
Gut Microbiota in Multiple Sclerosis: Possible Influence of Immunomodulators.
Teriflunomide (Aubagio) approved for use by the NHS in Scotland and Northern Ireland
Interferon beta for secondary progressive multiple sclerosis.
Glatiramer acetate ameliorates inflammatory bowel disease in mice through the induction of Qa-1-restricted CD8⁺ regulatory cells.
Stopping Disease Modifying Therapy in Progressive Multiple Sclerosis - A Prospective Study
Drug Safety Labeling Changes
Rituximab monitoring and redosing in pediatric neuromyelitis optica spectrum disorder.
The immunopathology of multiple sclerosis: an overview.
Association of British Neurologists: revised (2015) guidelines for prescribing disease-modifying treatments in multiple sclerosis.
Antigen-specific tolerance by autologous myelin Peptide-coupled cells: a phase 1 trial in multiple sclerosis.
Safety and efficacy of mitoxantrone in pediatric patients with aggressive multiple sclerosis.
Recent advances in the drug discovery of metabotropic glutamate receptor 4 (mGluR4) activators for the treatment of CNS and non-CNS disorders.
JC Virus in CD34+ and CD19+ Cells in Patients With Multiple Sclerosis Treated With Natalizumab.
Urodynamic and physiologic patterns associated with the common causes of neurogenic bladder in adults.
New insights into signaling during myelination in zebrafish.
A Study to Evaluate the Safety and Effectiveness of Novantrone Therapy Followed by Copaxone for Multiple Sclerosis
Daclizumab high-yield process in relapsing-remitting multiple sclerosis (SELECT): a randomised, double-blind, placebo-controlled trial.
GNbAC1, a humanized monoclonal antibody against the envelope protein of multiple sclerosis-associated endogenous retrovirus: a first-in-humans randomized clinical study.
Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group.

Pages